106 related articles for article (PubMed ID: 36257901)
1. Concordance between clinical and pathologic assessment of T and N stages of rectal adenocarcinoma patients who underwent surgery without neoadjuvant therapy: A National Cancer Database analysis.
Emile SH; Silva-Alvarenga E; Horesh N; Freund MR; Garoufalia Z; Wexner SD
Eur J Surg Oncol; 2023 Feb; 49(2):426-432. PubMed ID: 36257901
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic accuracy of 3.0T high-resolution MRI for assessment mesorectal lymph node metastases in patients with rectal cancer].
Chen Y; Yang X; Lu B; Xiao X; Zhuang X; Yu S
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jul; 21(7):786-792. PubMed ID: 30051447
[TBL] [Abstract][Full Text] [Related]
3. Concordance of MRI With Pathology for Primary Staging of Rectal Cancer in Routine Clinical Practice: A Single Institution Experience.
Kikano EG; Matalon SA; Eskian M; Lee L; Melnitchouk N; Bleday R; Khorasani R
Curr Probl Diagn Radiol; 2024; 53(1):68-72. PubMed ID: 37704486
[TBL] [Abstract][Full Text] [Related]
4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
5. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
Antunez AG; Kanters AE; Regenbogen SE
Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
[TBL] [Abstract][Full Text] [Related]
6. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
Garfinkle R; Lachance S; Vuong T; Mikhail A; Pelsser V; Gologan A; Morin NA; Vasilevsky CA; Boutros M
Dis Colon Rectum; 2019 Mar; 62(3):294-301. PubMed ID: 30741768
[TBL] [Abstract][Full Text] [Related]
7. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
8. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
9. Adding Narrow-Band Imaging to Chromoendoscopy for the Evaluation of Tumor Response to Neoadjuvant Therapy in Rectal Cancer.
Ishioka M; Chino A; Ide D; Saito S; Igarashi M; Nagasaki T; Akiyoshi T; Nagayama S; Fukunaga Y; Ueno M; Kawachi H; Yamamoto N; Fujisaki J; Konishi T
Dis Colon Rectum; 2021 Jan; 64(1):53-59. PubMed ID: 32639283
[TBL] [Abstract][Full Text] [Related]
10. Application value of biplane transrectal ultrasonography plus ultrasonic elastosonography and contrast-enhanced ultrasonography in preoperative T staging after neoadjuvant chemoradiotherapy for rectal cancer.
Xiao Y; Xu D; Ju H; Yang C; Wang L; Wang J; Hazle JD; Wang D
Eur J Radiol; 2018 Jul; 104():20-25. PubMed ID: 29857861
[TBL] [Abstract][Full Text] [Related]
11. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?
Chen CC; Lee RC; Lin JK; Wang LW; Yang SH
Dis Colon Rectum; 2005 Apr; 48(4):722-8. PubMed ID: 15747073
[TBL] [Abstract][Full Text] [Related]
12. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
[TBL] [Abstract][Full Text] [Related]
13. Current Imaging Modalities Understage One-Third of Patients with Stage I Rectal Cancer: Implications for Treatment Selection.
Dehal A; Graff-Baker AN; Vuong B; Nelson D; Chang SC; Goldfarb M; Bilchik AJ
Am Surg; 2018 Oct; 84(10):1589-1594. PubMed ID: 30747675
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of 3.0-tesla high-resolution magnetic resonance imaging for invasion depth of rectal cancer].
Yao X; Song X; Wang Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):668-74. PubMed ID: 27353102
[TBL] [Abstract][Full Text] [Related]
15. Clinical tumour size and nodal status predict pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Garland ML; Vather R; Bunkley N; Pearse M; Bissett IP
Int J Colorectal Dis; 2014 Mar; 29(3):301-7. PubMed ID: 24420737
[TBL] [Abstract][Full Text] [Related]
16. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
[No Abstract] [Full Text] [Related]
17. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
[TBL] [Abstract][Full Text] [Related]
19. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
20. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]